|
|
|
1 members (Alisa),
2,521
guests, and
21
robots. |
|
Key:
Admin,
Global Mod,
Mod
|
|
S |
M |
T |
W |
T |
F |
S |
|
|
|
|
|
1
|
2
|
3
|
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
|
11
|
12
|
13
|
14
|
15
|
16
|
17
|
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
|
25
|
26
|
27
|
28
|
29
|
30
|
31
|
|
There are no members with birthdays on this day. |
Volcano earthquake report for Friday, 16 October 2026
• M 3.1 - 202 km SE of Atka, Alaska
• M 2.3 - 40 km E of Chase, Alaska
• M 3.6 - 2 km NW of Knik, Alaska
• M 3.3 - 65 km NE of Punta Cana, Dominican Republic
• M 3.6 - 282 km ESE of Chiniak, Alaska
|
#833973
Mon 17 Aug 2026 08:30:AM
|
Joined: Feb 2001
Posts: 678,977
Launch Director
|
|
Launch Director
Joined: Feb 2001
Posts: 678,977 |
At 11, Payton Herres received a donated heart after years of health problems caused by Ebstein’s anomaly. Fifteen years later, she faced a fight to access everolimus, the anti-rejection medicine she had relied on since 2013. After her insurer stopped covering the drug and its cost rose sharply, Herres turned to social media. Her story went viral and reached Mark Cuban, whose pharmacy began supplying the medicine at a lower cost. Source: Heart transplant survivor fights to keep access to anti-rejection drug
|
|
CMS The Best Conveyancing solicitors conveyancing quotes throughout the UK
For any webhosting enquiries please email webmaster@aus-city.com
|
|
Entire Thread
|
Heart transplant survivor fights to keep access to anti-rejection drug
|
Webmaster
|
Mon 17 Aug 2026 08:30:AM
|
|
Forums60
Topics879,145
Posts913,942
Members2,960
| |
Most Online102,106
Jul 10th, 2026
|
|
|
|
|
|
